The Impact of Coexistence of Smoking and Diabetes on the Coronary Artery Severity and Outcomes following Percutaneous Coronary Intervention: Results from the 1^ST Jordanian PCI Registry

Table 2

Clinical presentation, coronary artery disease, and PCI indications in diabetic-smokers compared with the other 3 groups.

Clinical variable	Diabetic-smokers	Diabetic-nonsmokers	Nondiabetic-smokers	Nondiabetic-nonsmokers	value
Total number	467	833	588	538
Presentation:					0.0001
ACS (, %)	380 (81.4%)	610 (73.2%)	482 (82%)	398 (74%)
Stable coronary disease (, %)	87 (22.9%)	223 (26.8%)	106 (18%)	140 (26%)
STEMI (, %)	165 (35.3%)	184 (22.1%)	238 (40.5%)	139 (25.8%)	0.0001
NSTEMI (, %)	66 (14.13%)	85 (10.2%)	92 (15.6%)	63 (11.7%)
Multivessel CAD (, %)	195 (41.8%)	385 (46.2%)	211 (35.9%)	218 (40.5%)	0.001
Multivessel PCI (, %)	128 (27.4%)	279 (33.5%)	137 (23.3%)	144 (26.8%)	0.018
High GRACE risk score at discharge (highest tertile)	123 (26.3%)	353 (42.3%)	125 (21.3%)	230 (42.9%)	0.008
CRUSADE bleeding risk score (highest 2 pentile)	132 (28.6%)	533 (63.9%)	90 (15.3%)	189 (35.2%)	0.0001

ACS: acute coronary syndrome; CAD: coronary artery disease; GRACE risk score; CRUSADE bleeding risk score; STEMI: ST-segment elevation myocardial infarction.